Volume 8 Issue 1
Jan.  2017
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2017  >  8(1): 59-65
Zhang Quanbao, Tao Yifeng, Li Ruidong, et al. Orthotopic liver transplantation for treatment of hepatic epithelioid hemangioendothelioma: report of two cases and literature review[J]. ORGAN TRANSPLANTATION, 2017, 8(1): 59-65. doi: 10.3969/j.issn.1674-7445.2017.01.012
Citation: Zhang Quanbao, Tao Yifeng, Li Ruidong, et al. Orthotopic liver transplantation for treatment of hepatic epithelioid hemangioendothelioma: report of two cases and literature review[J]. ORGAN TRANSPLANTATION, 2017, 8(1): 59-65. doi: 10.3969/j.issn.1674-7445.2017.01.012
shu

Orthotopic liver transplantation for treatment of hepatic epithelioid hemangioendothelioma: report of two cases and literature review

doi: 10.3969/j.issn.1674-7445.2017.01.012

  • Department of General Surgery, Liver Transplantation Center, Huashan Hospital Affiliated to Fudan University, Shanghai 200040, China

More Information
  • Corresponding author: Wang Zhengxin, Email:778622916@qq.com
  • Received Date: 2016-09-20
    Available Online: 2021-01-19
  • Publish Date: 2017-01-15
    Abstract
  •   Objective  To investigate the clinical efficacy and therapeutic progress of orthotopic liver transplantation for the treatment of hepatic epithelioid hemangioendothelioma (EHE).  Methods  Clinical data of 2 patients diagnosed with hepatic EHE were retrospectively analyzed. One patient (case 1) was diagnosed with multiple hepatic EHE complicated with multiple infarction lesions of the spleen, and underwent orthotopic liver transplantation combined with splenectomy. The other case (case 2) was diagnosed with multiple hepatic EHE and received orthotopic liver transplantation alone. Literature review was performed. Pathological characteristics, clinical efficacy of liver transplantation and clinical prognosis of hepatic EHE patients were analyzed.  Results  Two patients successfully underwent surgery and were discharged postoperatively. The diagnosis of hepatic EHE was confirmed by pathological examination and case 1 was complicated with EHE of the spleen. For case 1, tacrolimus was replaced by sirolimus at postoperative 1 month. At postoperative 4 months, capecitabine was orally administered (chemotherapy) for EHE recurrence. At 6 months after surgery, the patient was diagnosed with recurrent hepatic EHE complicated with multiple bone metastases, and was orally administered with sorafenib. At postoperative 7 months, the patient died from cachexia and liver failure. Case 2 was followed up until the submission date (8 months after surgery). No postoperative complications and tumor recurrence were observed. Previous studies had demonstrated that surgical resection was the primary therapy of hepatic EHE. Liver transplantation was highly recommended for patients with multiple unresectable hepatic EHE and extra-hepatic lesions. Moreover, chemotherapy, percutaneous puncture combined with transcatheter arterial chemoembolization and anti-angiogenesis treatment exerted certain clinical efficacy.  Conclusions  Surgical resection remains the primary therapy of hepatic EHE. For patients with multiple intrahepatic EHE, liver transplantation is considered as the optimal treatment. Much attention should be diverted to the prevention and treatment of recurrent hepatic EHE following liver transplantation, aiming to improve the clinical efficacy.

     

    • FullText(HTML)
  • loading
    • References(30)
  • [1]
    Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma[J]. Cancer, 1982, 50(5): 970-981. doi: 10.1002/(ISSN)1097-0142
    [2]
    Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition[J]. Pathology, 2014, 46(2): 95-104. DOI: 10.1097/PAT.0000000000000050.
    [3]
    Ishak KG, Sesterhenn IA, Goodman ZD, et al. Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases[J]. Hum Pathol, 1984, 15(9): 839-852. doi: 10.1016/S0046-8177(84)80145-8
    [4]
    Rude MK, Watson R, Crippin JS. Recurrent hepatic epithelioid hemangioendothelioma after orthotopic liver transplantation[J]. Hepatology, 2014, 59(5): 2050-2052. DOI: 10.1002/hep.26891.
    [5]
    Lerut JP, Orlando G, Adam R, et al. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry[J]. Ann Surg, 2007, 246(6): 949-957. doi: 10.1097/SLA.0b013e31815c2a70
    [6]
    Rodriguez JA, Becker NS, O'Mahony CA, et al. Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005[J]. J Gastrointest Surg, 2008, 12(1): 110-116. doi: 10.1007/s11605-007-0247-3
    [7]
    孙淑杰, 迮兴宇, 赵新颜, 等.肝上皮样血管内皮瘤文献复习及临床特点分析[J].临床和实验医学杂志, 2012, 11(9): 654-656.DOI: 10.3969/j.issn.1671-4695.2012.09.006.Sun

    SJ, Ze XY, Zhao XY, et al. A review of literatures on clinical manifestations of hepatic epithelioid hemagioendothelioma[J]. J Clin Exp Med, 2012, 11(9): 654-656.DOI: 10.3969/j.issn.1671-4695.2012.09.006.
    [8]
    Grotz TE, Nagorney D, Donohue J, et al. Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option?[J]. HPB, 2010, 12(8): 546-553. DOI: 10.1111/j.1477-2574.2010.00213.x.
    [9]
    Otrock ZK, Al-Kutoubi A, Kattar MM, et al. Spontaneous complete regression of hepatic epithelioid haemangioendothelioma[J]. Lancet Oncol, 2006, 7(5): 439-441. doi: 10.1016/S1470-2045(06)70697-0
    [10]
    康锶鹏, 谢飞来, 郑智勇.肝脏上皮样血管内皮细胞瘤1例[J].世界华人消化杂志, 2015, 23(19): 3166-3170. DOI: 10.11569/wcjd.v23.i19.3166.

    Kang SP, Xie FL, Zheng ZY. Hepatic epithelioid haemangioendothelioma: report of one case[J]. World J Chin Dig, 2015, 23(19): 3166-3170. DOI: 10.11569/wcjd.v23.i19.3166.
    [11]
    张树辉, 丛文铭, 吴孟超, 等.肝上皮样血管内皮瘤的临床病理特点(附8例报告及文献复习)[J].中华肝胆外科杂志, 2003, 9(6): 327-330. DOI: 10.3760/cma.j.issn.1007-8118.2003.06.004.

    Zhang SH, Cong WM, Wu MC, et al. Epithelioid hemangioendothelioma of the liver: a clinicopathological study on 8 cases and review of literature[J]. Chin J Hepatobiliary Surg, 2003, 9(6): 327-330. DOI: 10.3760/cma.j.issn.1007-8118.2003.06.004.
    [12]
    Sardaro A, Bardoscia L, Petruzzelli MF, et al. Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor[J]. Oncol Rev, 2014, 8(2): 259. DOI: 10.4081/oncol.2014.259.
    [13]
    Errani C, Zhang L, Sung YS, et al. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites[J]. Genes Chromosomes Cancer, 2011, 50(8): 644-653. DOI: 10.1002/gcc.20886.
    [14]
    Antonescu CR, Le Loarer F, Mosquera JM, et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma[J]. Genes Chromosomes Cancer, 2013, 52(8): 775-784. DOI: 10.1002/gcc.22073.
    [15]
    Mascarelli PE, Iredell JR, Maggi RG, et al. Bartonella species bacteremia in two patients with epithelioid hemangioendothelioma[J]. J Clin Microbiol, 2011, 49(11): 4006-4012. DOI: 10.1128/JCM.05527-11.
    [16]
    陈漪.肝上皮样血管内皮瘤的诊断与鉴别诊断[J].实用肝脏病杂志, 2013, 16(5): 398-400. DOI: 10.3969/j.issn.1672-5069.2013.05.005.

    Chen Y. The diagnosis and differential diagnosis of hepatic epithelioid hemangioendothelioma[J]. J Clin Hepatol, 2013, 16(5): 398-400. DOI: 10.3969/j.issn.1672-5069.2013.05.005.
    [17]
    周丽莎, 翟凤仪, 董帜, 等.肝脏上皮样血管内皮瘤的CT和MRI表现[J].临床放射学杂志, 2015, 34(3): 402-405. http://www.cnki.com.cn/Article/CJFDTOTAL-LCFS201503022.htm

    Zhou LS, Zhai FY, Dong Z, et al. CT and MRI features of hepatic epithelioid hemangioendotheliomas[J]. J Clin Radiol, 2015, 34(3): 402-405. http://www.cnki.com.cn/Article/CJFDTOTAL-LCFS201503022.htm
    [18]
    吕鹏, 林江, 周易, 等.肝脏上皮样血管内皮瘤:影像表现和病理基础[J].中国医学计算机成像杂志, 2011, 17(5): 416-419. DOI: 10.3969/j.issn. 1006-5741.2011.05.007.

    Lyu P, Lin J, Zhou Y, et al. Hepatic epithelioid hemangioendothelioma: imaging and pathologic findings[J]. Chin Comp Med Imag, 2011, 17(5): 416-419.DOI: 10.3969/j.issn.1006-5741.2011.05.007.
    [19]
    Yousaf N, Maruzzo M, Judson I, et al. Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience[J]. Anticancer Res, 2015, 35(1): 473-480. http://ar.iiarjournals.org/content/35/1/473.full
    [20]
    Mehrabi A, Kashfi A, Fonouni H, et al. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy[J]. Cancer, 2006, 107(9): 2108-2121. doi: 10.1002/(ISSN)1097-0142
    [21]
    Nudo CG, Yoshida EM, Bain VG, et al. Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience[J]. Can J Gastroenterol, 2008, 22(10): 821-824. doi: 10.1155/2008/418485
    [22]
    孙雁.肝脏上皮样血管内皮瘤行肝移植术的治疗体会[J].天津医药, 2009, 37(11): 983-984. DOI: 10.3969/j.issn.0253-9896.2009.11.032.

    Sun Y. Experience in the treatment of liver transplantation for hepatic epithelioid hemangioendothelioma[J]. Tianjin Med J, 2009, 37(11): 983-984. DOI: 10.3969/j.issn.0253-9896.2009.11.032.
    [23]
    周健鞠, 卫强, 何晓顺, 等.肝移植治疗肝脏上皮样血管内皮瘤2例报告并文献复习[J/CD].中华普通外科学文献(电子版), 2012, 6(4): 318-321. DOI: 10.3877/cma.j.issn.1674-0793.2012.04.009.

    Zhou JJ, Wei Q, He XS, et al. Liver transplantation for hepatic epithelioid hemangioendothelioma: report of two cases and review of the literature[J/CD]. Chin Arch Gen Surg (Electr Edit), 2012, 6(4): 318-321.DOI: 10.3877/cma.j.issn.1674-0793.2012.04.009.
    [24]
    Demir L, Can A, Oztop R, et al. Malignant epithelioid hemangioendothelioma progressing after chemotherapy and interferon treatment: a case presentation and a brief review of the literature[J]. J Cancer Res Ther, 2013, 9(1): 125-127. DOI: 10.4103/0973-1482.110386.
    [25]
    St Peter SD, Moss AA, Huettl EA, et al. Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendothelioma[J]. Clin Transplant, 2003, 17(6): 549-553. doi: 10.1046/j.1399-0012.2003.00055.x
    [26]
    Wang LR, Zhou JM, Zhao YM, et al. Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients[J]. World J Surg, 2012, 36(11): 2677-2683. DOI: 10.1007/s00268-012-1714-x.
    [27]
    Salech F, Valderrama S, Nervi B, et al. Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with along term follow-up[J]. Ann Hepatol, 2011, 10(1): 99-102.
    [28]
    Pallotti MC, Nannini M, Agostinelli C, et al. Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma[J]. World J Gastroenterol, 2014, 20(22): 7049-7054. DOI: 10.3748/wjg.v20.i22.7049.
    [29]
    Agulnik M, Yarber JL, Okuno SH, et al. An open-label, multicenter, phase Ⅱ study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas[J]. Ann Oncol, 2013, 24(1): 257-263. DOI: 10.1093/annonc/mds237.
    [30]
    Chevreau C, Le Cesne A, Ray-Coquard I, et al. Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO)[J]. Cancer, 2013, 119(14): 2639-2644. DOI: 10.1002/cncr.28109.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (238) PDF downloads(8) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return